Moors & Cabot, Inc. Merck & Co., Inc. Transaction History

Moors & Cabot, Inc.

$1.81 Billion
Q1 2024

A detailed history of Moors & Cabot, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 144,178 shares of MRK stock, worth $18.4 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

144,178

Previous 142,047 1.5%

Holding current value

$18.4 Million

Previous $15.5 Million 22.85%

% of portfolio

1.05%

Previous 0.98%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$113.24 - $131.95 $241,314 - $281,185	2,131 Added 1.5%	144,178 $19 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $122,319 - $133,113	-1,221 Reduced 0.85%	142,047 $15.5 Million
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $295,569 - $328,241	-2,871 Reduced 1.96%	143,268 $14.7 Million
Q2 2023 Aug 09, 2023	SELL	$108.61 - $118.38 $113,931 - $124,180	-1,049 Reduced 0.71%	146,139 $16.9 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $380,775 - $424,867	-3,699 Reduced 2.45%	147,188 $15.7 Million

Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $2.38 Million - $3.05 Million	27,245 Added 22.04%	150,887 $16.7 Million
Q4 2022 Feb 06, 2023	SELL	$87.44 - $112.11 $2.09 Million - $2.67 Million	-23,855 Reduced 16.17%	123,642 $13.7 Million
Q3 2022 Nov 07, 2022	SELL	$84.53 - $94.96 $251,054 - $282,031	-2,970 Reduced 1.97%	147,497 $12.7 Million
Q2 2022 Aug 08, 2022	BUY	$83.49 - $94.64 $420,789 - $476,985	5,040 Added 3.47%	150,467 $13.7 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $995,619 - $1.12 Million	13,544 Added 10.27%	145,427 $11.9 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $166,749 - $208,875	2,307 Added 1.78%	131,883 $10.1 Million
Q3 2021 Dec 08, 2021	BUY	$71.68 - $78.83 $7.5 Million - $8.24 Million	104,576 Added 418.3%	129,576 $9.77 Million
Q3 2021 Nov 05, 2021	SELL	$71.68 - $78.83 $6.62 Million - $7.28 Million	-92,289 Reduced 78.69%	25,000 $27,000
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $5,062 - $5,599	-72 Reduced 0.06%	117,289 $9.12 Million
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $164,919 - $194,258	-2,395 Reduced 2.0%	117,361 $9.05 Million
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $8,612 - $9,558	-120 Reduced 0.1%	119,756 $9.78 Million
Q3 2020 Nov 09, 2020	SELL	$73.18 - $82.95 $77,278 - $87,595	-1,056 Reduced 0.87%	119,876 $9.94 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $441,392 - $502,254	6,268 Added 5.47%	120,932 $9.35 Million
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $463,098 - $641,876	-7,309 Reduced 5.99%	114,664 $8.82 Million
Q4 2019 Jan 28, 2020	BUY	$77.58 - $87.54 $56,555 - $63,816	729 Added 0.6%	121,973 $11.1 Million
Q3 2019 Oct 22, 2019	BUY	$76.08 - $82.93 $536,211 - $584,490	7,048 Added 6.17%	121,244 $10.2 Million
Q2 2019 Jul 18, 2019	BUY	$69.84 - $81.59 $189,545 - $221,435	2,714 Added 2.43%	114,196 $9.58 Million
Q1 2019 May 06, 2019	SELL	$69.58 - $79.36 $7.76 Million - $8.85 Million	-111,482 Reduced 50.0%	111,482 $9.27 Million
Q1 2019 May 01, 2019	BUY	$69.58 - $79.36 $7.98 Million - $9.1 Million	114,718 Added 105.98%	222,964 $18.5 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $617,300 - $716,368	-9,462 Reduced 8.04%	108,246 $8.26 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $5,019 - $5,902	87 Added 0.07%	117,708 $8.34 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $72,636 - $85,339	1,429 Added 1.23%	117,621 $7.12 Million
Q1 2018 May 18, 2018	BUY	$50.96 - $59.23 $376,186 - $437,235	7,382 Added 6.78%	116,192 $6.33 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $645,456 - $770,746	12,504 Added 12.98%	108,810 $6.12 Million
Q3 2017 Nov 16, 2017	BUY	$58.67 - $63.13 $1.27 Million - $1.37 Million	21,698 Added 29.08%	96,306 $6.16 Million
Q2 2017 Aug 15, 2017	BUY	N/A	74,608	74,608 $4.78 Million

Others Institutions Holding MRK

# of Institutions

3,767

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $324B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account